BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1617334)

  • 21. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
    Prud'homme GJ
    J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Toh ML; Miossec P
    Curr Opin Rheumatol; 2007 May; 19(3):284-8. PubMed ID: 17414957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
    VanderBorght A; Geusens P; Raus J; Stinissen P
    Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases.
    Fathman CG
    Rheum Dis Clin North Am; 1992 Nov; 18(4):915-26. PubMed ID: 1280848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble T cell receptors: novel immunotherapies.
    Molloy PE; Sewell AK; Jakobsen BK
    Curr Opin Pharmacol; 2005 Aug; 5(4):438-43. PubMed ID: 15939669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
    Wauben MH
    Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell therapy for autoimmune diseases: does it have a future?
    Radbruch A; Thiel A
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii96-ii101. PubMed ID: 15479883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of T-cell antigen receptors in rheumatic diseases].
    Su ZG; Manolios N; Shi GY
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):54-7. PubMed ID: 8045189
    [No Abstract]   [Full Text] [Related]  

  • 36. T-cell receptor peptides as immunotherapy for autoimmune disease.
    Gold DP; Shroeder K; Golding A; Brostoff SW; Wilson DB
    Crit Rev Immunol; 1997; 17(5-6):507-10. PubMed ID: 9419437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific immunotherapies in rheumatic diseases.
    Pozsgay J; Szekanecz Z; Sármay G
    Nat Rev Rheumatol; 2017 Sep; 13(9):525-537. PubMed ID: 28701761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific therapies in multiple sclerosis.
    Sospedra M; Martin R
    Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of effective immunotherapy for human autoimmunity.
    Feldmann M; Steinman L
    Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.